Glenmark Life Sciences Ltd - Stock Price

As on22 Oct 2021
  • NSE : GLS
  • BSE : 543322
  • ISIN CODE : INE03Q201024
  • Industry : Pharmaceuticals & Drugs
  • House : Glenmark
Glenmark Life Sciences Ltd is not traded on BSE/NSE
NSE
618.10
-1.69 %-10.6
BSE
618.30
-1.61 %-10.1

Balance Sheet

Parameter MAR 21  MAR 20  YoY %Change
EQUITY AND LIABILITIESNANANA
Share Capital19.6019.600.00
    Equity - Authorised400.00140.00185.71
    Equity - Issued19.6019.600.00
    Equity Paid Up19.6019.600.00
    Equity Shares Forfeited0.000.000.00
    Adjustments to Equity0.000.000.00
    Preference Capital Paid Up0.000.000.00
    Face Value2.0010.00-80.00
Share Warrants & Outstandings0.000.000.00
Total Reserves7507.873997.3287.82
    Securities Premium0.000.000.00
    Capital Reserves0.000.000.00
    Profit & Loss Account Balance7507.873997.3287.82
    General Reserves0.000.000.00
    Other Reserves0.000.000.00
Reserve excluding Revaluation Reserve7507.873997.3287.82
Revaluation reserve0.000.000.00
Shareholder's Funds7527.474016.9287.39
Minority Interest0.000.000.00
Long-Term Borrowings0.000.000.00
Secured Loans0.000.000.00
    Non Convertible Debentures0.000.000.00
    Converible Debentures & Bonds0.000.000.00
    Packing Credit - Bank0.000.000.00
    Inter Corporate & Security Deposit0.000.000.00
    Term Loans - Banks0.000.000.00
    Term Loans - Institutions0.000.000.00
    Other Secured0.000.000.00
Unsecured Loans0.000.000.00
    Fixed Deposits - Public0.000.000.00
    Loans and advances from subsidiaries0.000.000.00
    Inter Corporate Deposits (Unsecured)0.000.000.00
    Foreign Currency Convertible Notes0.000.000.00
    Long Term Loan in Foreign Currency0.000.000.00
    Loans - Banks0.000.000.00
    Loans - Govt.0.000.000.00
    Loans - Others0.000.000.00
    Other Unsecured Loan0.000.000.00
Deferred Tax Assets / Liabilities228.88164.4839.15
    Deferred Tax Assets20.261.311446.56
    Deferred Tax Liability249.14165.7950.27
Other Long Term Liabilities0.000.000.00
Long Term Trade Payables0.000.000.00
Long Term Provisions0.000.000.00
Total Non-Current Liabilities228.88164.4839.15
Current LiabilitiesNANANA
Trade Payables2213.052010.7110.06
    Sundry Creditors2213.052010.7110.06
    Acceptances0.000.000.00
    Due to Subsidiaries- Trade Payables0.000.000.00
Other Current Liabilities9665.4010840.29-10.84
    Bank Overdraft / Short term credit0.000.000.00
    Advances received from customers72.9054.1034.75
    Interest Accrued But Not Due0.000.000.00
    Share Application Money0.000.000.00
    Current maturity of Debentures & Bonds0.000.000.00
    Current maturity - Others0.000.000.00
    Other Liabilities9592.5010786.19-11.07
Short Term Borrowings0.000.21-100.00
    Secured ST Loans repayable on Demands0.000.000.00
    Working Capital Loans- Sec0.000.000.00
    Buyers Credits - Unsec0.000.000.00
    Commercial Borrowings- Unsec0.000.000.00
    Other Unsecured Loans0.000.21-100.00
Short Term Provisions335.95223.4350.36
    Proposed Equity Dividend0.000.000.00
    Provision for Corporate Dividend Tax0.000.000.00
    Provision for Tax136.9383.6063.79
    Provision for post retirement benefits0.000.000.00
    Preference Dividend0.000.000.00
    Other Provisions199.02139.8342.33
Total Current Liabilities12214.4013074.64-6.58
Total Liabilities19970.7517256.0415.73
ASSETSNANANA
Gross Block6518.985948.219.60
Less: Accumulated Depreciation790.99485.7562.84
Less: Impairment of Assets0.000.000.00
Net Block5727.995462.464.86
Lease Adjustment A/c0.000.000.00
Capital Work in Progress140.98107.3031.39
Non Current Investments0.770.770.00
Long Term Investment0.770.770.00
    Quoted0.000.000.00
    Unquoted0.770.770.00
Long Term Loans & Advances110.6084.3731.09
Other Non Current Assets0.000.000.00
Total Non-Current Assets5980.345654.905.76
Current Assets Loans & AdvancesNANANA
Currents Investments0.000.000.00
    Quoted0.000.000.00
    Unquoted0.000.000.00
Inventories5134.214127.7524.38
    Raw Materials1170.22864.8635.31
    Work-in Progress3418.942716.9825.84
    Finished Goods350.76345.711.46
    Packing Materials11.5110.598.69
    Stores  and Spare182.78189.61-3.60
    Other Inventory0.000.000.00
Sundry Debtors6195.006386.28-3.00
    Debtors more than Six months0.000.000.00
    Debtors Others6195.006386.28-3.00
Cash and Bank1155.9699.981056.19
    Cash in hand1.101.100.00
    Balances at Bank1154.8698.881067.94
    Other cash and bank balances0.000.000.00
Other Current Assets703.11337.12108.56
    Interest accrued on Investments0.000.000.00
    Interest accrued on Debentures0.000.000.00
    Deposits with Government0.000.000.00
    Interest accrued and or due on loans0.000.000.00
    Prepaid Expenses9.423.35181.19
    Other current_assets693.69333.77107.83
Short Term Loans and Advances802.13650.0123.40
    Advances recoverable in cash or in kind774.08650.0119.09
    Advance income tax and TDS0.000.000.00
    Amounts due from directors0.000.000.00
    Due From Subsidiaries0.000.000.00
    Inter corporate deposits0.000.000.00
    Corporate Deposits0.000.000.00
    Other Loans & Advances28.050.000.00
Total Current Assets13990.4111601.1420.60
Net Current Assets (Including Current Investments)1776.01-1473.50220.53
Miscellaneous Expenses not written off0.000.000.00
Total Assets19970.7517256.0415.73
Contingent Liabilities22.1622.160.00
Total Debt0.000.21-100.00
Book Value768.112049.45-62.52
Adjusted Book Value69.8337.2687.39

About Glenmark Life Sciences Ltd.

Glenmark Life Sciences Ltd. was incorporated in the year 2011. Its today's share price is 618.3. Its current market capitalisation stands at Rs 7575.86 Cr. In the latest quarter, company has reported Gross Sales of Rs. 18851.65 Cr and Total Income of Rs.18859.76 Cr. The company's management includes Gita Nayyar, Taruvai Laxminarayanan Easwar, Manju Agarwal, Sridhar Gorthi, Sumantra Mitra, Yasir Rawjee, VS Mani, Glenn Saldanha, Rudalf Corriea.

It is listed on the BSE with a BSE Code of 543322 , NSE with an NSE Symbol of GLS and ISIN of INE03Q201024. It's Registered office is at Plot No. 170-172,Chandramouli Industrial Estate,Mohol BazarpethSolapur-413213, Maharashtra. Their Registrars are ACC Ltd. It's auditors are Walker Chandiok & Co LLP

Latest News

close